Zepp Health Corporation

NYSE: ZEPP · Real-Time Price · USD
33.53
-1.58 (-4.50%)
At close: Aug 15, 2025, 3:59 PM
33.33
-0.60%
After-hours: Aug 15, 2025, 07:57 PM EDT

Zepp Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
199.95M 435.87M 684.57M 1.22B 1.78B 2.14B 2.5B 2.97B 3.57B 4.03B 4.14B 4.73B 5.13B 5.86B 6.25B 6.56B 7.19B 6.49B
Cost of Revenue
124.92M 263.45M 420.83M 774.6M 1.15B 1.48B 1.84B 2.3B 2.87B 3.28B 3.34B 3.83B 4.14B 4.66B 4.94B 5.2B 5.69B 5.15B
Gross Profit
75.03M 172.42M 263.74M 450.12M 636.96M 660.61M 657.78M 671.31M 697.92M 753.72M 803.12M 901.92M 994.98M 1.2B 1.31B 1.36B 1.5B 1.35B
Operating Income
-45.95M -49.72M -145.08M -130.8M -107.42M -169.93M -207.1M -283.39M -367.49M -405.72M -410.24M -329.23M -193.49M -11.29M 93.94M 147.58M 165.69M 103.5M
Interest Income
2.59M 3.24M 3.67M 8.86M 8.73M 8.63M 8.22M 2.93M 2.58M 2.05M 1.85M 1.66M 1.75M 2.13M 2.6M 16.57M 17.53M 18.76M
Pretax Income
-59.53M -63.01M -144.96M -130.44M -114.02M -179.29M -236.79M -308.37M -366.22M -422.14M -372.53M -273.08M -164.55M 46.17M 106.67M 217.38M 251.54M 196.69M
Net Income
-77.61M -80.7M -166.49M -138.04M -121.82M -180.92M -209.38M -275.98M -299.58M -348.27M -306.66M -195.31M -125.34M 85.86M 137.8M 216.69M 248.42M 169.16M
Selling & General & Admin
75.52M 74.5M 177.41M 280.58M 380.25M 490.47M 503.07M 558.55M 616.52M 670.85M 696.24M 734.58M 710.63M 701.81M 696.62M 661.18M 715.17M 670.81M
Research & Development
45.45M 112.91M 196.67M 265.61M 329.39M 340.07M 361.81M 396.15M 448.89M 488.59M 517.12M 496.56M 477.85M 509.16M 515.08M 550.87M 615.1M 572M
Other Expenses
n/a n/a 489K 1.33M -401K -1.18M -3.66M -5.01M -3.28M -179K 1.81M 2.32M 4.06M 1.53M 4.03M 4.03M 2.29M 3.64M
Operating Expenses
120.97M 283.96M 470.63M 642.75M 806.2M 830.54M 864.88M 954.7M 1.07B 1.16B 1.21B 1.23B 1.19B 1.21B 1.21B 1.21B 1.33B 1.24B
Interest Expense
5.34M 5.47M 5.55M 14.5M 14.82M 15.2M 15.7M 7.83M 8.33M 8.68M 8.59M 8.39M 8.36M 7.85M 7.03M 4.69M 3.71M 3.25M
Selling & Marketing Expenses
51.04M 49.54M 113.02M 186.23M 244.9M 305.9M 314.56M 353.19M 406.47M 443.18M 460.3M 487.31M 454.16M 450.59M 438.27M 403.03M 427.94M 394.6M
Cost & Expenses
245.9M 547.41M 891.47M 1.42B 1.95B 2.31B 2.7B 3.25B 3.94B 4.44B 4.55B 5.06B 5.33B 5.87B 6.16B 6.41B 7.02B 6.39B
Income Tax Expense
14.39M 14.2M 14.6M 21.07M 21.09M 9.43M -15.82M -38.38M -72.46M -73.86M -65.88M -62.86M -23.03M 1.6M 10.74M 28.44M 30.64M 21.52M
Shares Outstanding (Basic)
3.96M 3.86M 4.04M 16.15M 16.18M 16.22M 15.1M 16.01M 15.07M 15.26M 15.23M 15.26M 15.19M 15.59M 15.85M 15.78M 15.74M 15.67M
Shares Outstanding (Diluted)
3.96M 4.01M 4.04M 16.15M 16.18M 16.22M 15.1M 16.01M 15.22M 15.32M 15.3M 15.32M 15.36M 15.59M 16.52M 16.64M 16.47M 15.67M
EPS (Basic)
-16.96 -15.72 -17.12 -8.56 -7.56 -11.52 -13.8 -18.16 -19.72 -22.88 -20 -12.84 -8.28 5.44 8.80 13.92 16.00 10.88
EPS (Diluted)
-16.96 -15.72 -17.12 -8.56 -7.56 -11.48 -13.72 -18.08 -19.64 -22.76 -19.92 -12.76 -8.36 4.96 8.32 13.12 15.04 10.24
EBITDA
-54.2M -57.54M -145.59M -114.43M -77.43M -135.55M -178.34M -257.57M -314.79M -353.71M -354.09M -263.96M -162.98M 21.53M 128.71M 116.15M 131.77M 62.81M
EBIT
-54.2M -57.54M -52.39M -33.51M -19.91M -19.93M -28.29M -38.22M -45.8M -54.23M -48.43M -32.39M -16.42M 14.95M 23.9M 28.41M 31.99M 22.71M
Depreciation & Amortization
1.03M 8.84M 22.46M 36.07M 49.69M 56.53M 57.58M 58.62M 56.93M 55.25M 53.57M 51.88M 45.7M 39.51M 33.32M 27.13M 24.65M 22.17M